Cargando…

Single-Center Contemporary Clinical Outcomes after Endovascular Treatment in Patients with De Novo Femoropopliteal Lesions between 2017 and 2019

Background: Drug-coated balloons (DCBs) and drug-eluting stents (DES) were available for treating femoropopliteal disease since 2017 and 2019. However, there are few reports to investigate whether approval of DCB and DES improved primary patency in clinical practice. Materials and Methods: We divide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Kazunori, Tanaka, Akiko, Taguri, Masataka, Tada, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064300/ https://www.ncbi.nlm.nih.gov/pubmed/37006868 http://dx.doi.org/10.3400/avd.oa.22-00081

Ejemplares similares

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Endovascular revascularization of heavily calcified occlusion in superior mesenteric artery using Transcollateral approach
por: Horie, Kazunori, et al.
Publicado: (2021)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Erratum to “Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices”
por: Isawa, Tsuyoshi, et al.
Publicado: (2020)

Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices
por: Isawa, Tsuyoshi, et al.
Publicado: (2020)

Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions
por: Kluckner, Michaela, et al.
Publicado: (2023)

Ultrasound-guided puncture reduces bleeding-associated complications, regardless of calcified plaque, after endovascular treatment of femoropopliteal lesions, especially using the antegrade procedure: A single-center study
por: Fukuda, Kentaro, et al.
Publicado: (2021)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

Endovascular Sharp Recanalization for Calcified Femoropopliteal Artery Occlusion
por: Huang, Hsuan-Li, et al.
Publicado: (2012)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
por: Gahide, Gérald, et al.
Publicado: (2021)

Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study
por: Guo, Xiangjiang, et al.
Publicado: (2015)

Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
por: Kluckner, Michaela, et al.
Publicado: (2022)

State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022)

Popliteal access for endovascular procedures in femoropopliteal artery occlusive disease
por: Yilmaz, Seyhan, et al.
Publicado: (2023)

Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions
por: Yanaka, Koji, et al.
Publicado: (2021)

When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?
por: AbuRahma, Ali F.
Publicado: (2018)

Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
por: Naiem, Ahmed A, et al.
Publicado: (2021)

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass
por: Rumba, Roberts, et al.
Publicado: (2023)

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
por: Katsanos, Konstantinos, et al.
Publicado: (2016)

Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease
por: de Athayde Soares, Rafael, et al.
Publicado: (2019)

Morphologic Changes of the Femoropopliteal Arterial Segment with Knee Flexion after Endovascular Therapy
por: Sato, Katsutoshi, et al.
Publicado: (2019)

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022)

Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis
por: Koeckerling, David, et al.
Publicado: (2023)

Intravascular Ultrasound–Guided Femoropopliteal Endovascular Intervention: Could it Become a Standard Procedure?
por: Murata, Naotaka
Publicado: (2023)

Efficacy of Super Slow Inflation as Lesion Preparation for Drug-Coated Balloons in Femoropopliteal Lesions
por: Sugihara, Makoto, et al.
Publicado: (2020)

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
por: Bishu, Kalkidan, et al.
Publicado: (2015)

Outcomes of Popliteal-To-Distal Bypass Combined with Femoropopliteal Artery Endovascular Treatment for Critical Limb Ischemia
por: Tsuji, Yoshihiko, et al.
Publicado: (2017)

Endovascular revascularization of TASC C and D femoropopliteal occlusive disease using carbon dioxide as contrast
por: Mendes, Cynthia de Almeida, et al.
Publicado: (2016)

A Single-Center Study on the Outcomes of Target Limb Revascularization in Femoropopliteal Lesions Treated With Drug Coated Balloons and Bare Metal Stents
por: Linehan, Victoria, et al.
Publicado: (2022)

Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Contemporary follow-up imaging after endovascular repair of lower extremity atherosclerotic lesions
por: Michalska, Marta, et al.
Publicado: (2018)

A prospective, multicenter, real-world observational study evaluating the impact of tibial runoff on clinical outcomes after endovascular therapy for femoropopliteal lesions: Research protocol
por: Liu, Yang, et al.
Publicado: (2022)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Radiocesium Concentration in Commercially-Available Foods Produced in Japan: 2017-2019
por: Nabeshi, Hiromi, et al.
Publicado: (2022)

Paclitaxel-coated balloons angioplasties for extra-long femoropopliteal artery atherosclerotic lesions (> 30 cm):12 months outcomes from a single center
por: Pan, Tao, et al.
Publicado: (2022)

Clinical Outcomes of the Intraluminal Approach for Long Occlusive Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Mori, Shinsuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u4oa51nnhtgtiptfon4mg8717k